Irene Blair was expected to have another six to eight months to live in June, after her pancreatic cancer rapidly advanced to ...

By Dennis Thompson HealthDay ReporterTUESDAY, Jan. 6, 2026 (HealthDay News) — A drug that mimics the female hormone ...

The startup is developing a medicine that can very specifically degrade cancerous forms of EGFR, the target of several ...

Pharmaceuticals giant, Merck & Co. Inc. (NYSE: MRK), is reportedly in talks to acquire cancer drug-maker Revolution Medicines ...

Researchers discovered a promising leukemia drug breakthrough that could help patients overcome treatment resistance, ...

Amgen Inc. has acquired cancer drug developer Dark Blue Therapeutics Ltd. in a deal worth as much as $840 million, expanding ...

AnaptysBio said on Thursday it filed a partial motion to dismiss a claim by GSK's oncology unit, which alleges the biotech ...

The FDA and European Medicines Agency (EMA) have awarded orphan drug designation to CPI-008 (cRGD-ZW800-1), a novel ...

Researchers at University of California San Diego School of Medicine have led the first clinical trial in the world to show that cancer drug treatments can be safely and effectively personalized based ...

A redesigned immune-activating cancer drug has produced striking early results in a small clinical trial, shrinking tumors ...

Common diabetes drugs may do more than regulate blood sugar—they could also influence how cancers grow, spread, or slow down.

# “While aspirin has been studied for colorectal cancer prevention, its modest benefit and bleeding risks limit its use.